CSTL - CIK 0001447362
The table below shows CASTLE BIOSCIENCES INC's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $64.35M | $64.87M | -$5.63M | -$41.66M | -$18.98M | $9.87M |
| Capital expenditure | $36.02M | $28.33M | $13.62M | $5.63M | $3.48M | $4.75M |
| Investing cash flow | -$60.37M | -$50.14M | -$16.18M | -$166.54M | -$66.66M | -$4.75M |
| Dividends paid | - | - | - | - | - |
CASTLE BIOSCIENCES INC reported operating cash flow of $64.35M for fiscal year 2025. That is down 0.8% from $64.87M in fiscal 2024. Over the 8 fiscal years shown, operating cash flow grew from -$12.29M (FY 2018) to $64.35M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | -$6.96M | $6.14M | -$2.30M | $1.51M | $5.42M | $305.89M |